Respiratory viral infections post-lung transplantation

Area of Science:

• Pulmonology
• Infectious Diseases
• Transplant Immunology

Background:

• Community-acquired respiratory viruses (CARVs) are prevalent pathogens in lung transplant recipients.
• CARV infections are linked to severe complications, including pneumonia, respiratory failure, and mortality.
• CARVs are increasingly implicated as risk factors for acute rejection (AR) and bronchiolitis obliterans syndrome (BOS).

Purpose of the Study:

• To highlight the significant impact of CARVs on lung transplant recipients.
• To underscore the limitations in current treatment options for CARV infections.
• To emphasize the need for deeper understanding of immune responses and allograft dysfunction for novel therapeutic development.

Main Methods:

• Literature review and synthesis of current research on CARV infections in lung transplant recipients.
• Analysis of diagnostic advancements and their impact on CARV detection.
• Examination of the association between CARVs, AR, and BOS.

Main Results:

• CARV infections contribute to a wide spectrum of adverse outcomes, from upper respiratory symptoms to fatal pneumonia.
• CARVs are recognized as critical factors influencing long-term graft survival and function.
• Despite improved diagnostics, effective antiviral therapies for CARVs remain scarce.

Conclusions:

• CARV infections represent a major threat to lung transplant recipients, exacerbating morbidity and mortality.
• Further investigation into the immunopathology of CARV infections is crucial.
• Development of novel management strategies is essential to mitigate the adverse effects of CARVs on lung allografts.